Literature DB >> 16133424

Endo/exo-proteolysis in neoplastic progression and metastasis.

Abdel-Majid Khatib, Daniel Bassi, Geraldine Siegfried, Andres J P Klein-Szanto, L'Houcine Ouafik.   

Abstract

Biological control of individual cells, organs, and organisms is achieved through interplay of a host of specific interactions that involve various peptidic molecules as modulators or effectors. In tumor cells, these processes may result in uncontrolled growth as a consequence of autocrine and/or paracrine actions. In recent years, growing evidence has accumulated for the important role of proprotein convertases (PCs) and peptide alpha-amidation enzymes in these processes. The widespread belief that these enzymes are involved in the major features of tumor progression, namely, invasiveness and metastasis, has taken place because of their capacity to process and activate many protein precursors involved in the neoplastic progression and metastasis. This includes degrading extracellular matrix proteases, growth promoting factors, and adhesion molecules. Usually, when the processing of these precursor proteins is achieved by one or more of the known PC family members within the general motif (K/R)-(X)n-(K/R) downward arrow, where n=0, 2, 4, or 6, and X, any amino acid except Cys, the accomplishment of the maturation of these molecules is attained by various posttranslational modifications, including the carboxy-terminal alpha-amidation. This review article summarizes recent findings on the role of these enzymatic systems in multiple cellular functions that impact on the invasive/metastatic potential of cancer cells and highlight the potential use of their inhibitors in the treatment of multiple cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133424     DOI: 10.1007/s00109-005-0692-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  77 in total

Review 1.  Regulation of prostatic growth and function by peptide growth factors.

Authors:  Z Culig; A Hobisch; M V Cronauer; C Radmayr; A Hittmair; J Zhang; M Thurnher; G Bartsch; H Klocker
Journal:  Prostate       Date:  1996-06       Impact factor: 4.104

2.  Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA.

Authors:  J W Creemers; A J Roebroek; W J Van de Ven
Journal:  FEBS Lett       Date:  1992-03-23       Impact factor: 4.124

3.  Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin.

Authors:  W Lu; W Zhang; S S Molloy; G Thomas; K Ryan; Y Chiang; S Anderson; M Laskowski
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells.

Authors:  J C Willey; J F Lechner; C C Harris
Journal:  Exp Cell Res       Date:  1984-07       Impact factor: 3.905

5.  Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.

Authors:  Samantha Fernandez-Sauze; Christine Delfino; Kamel Mabrouk; Christophe Dussert; Olivier Chinot; Pierre-Marie Martin; Francois Grisoli; L'Houcine Ouafik; Françoise Boudouresque
Journal:  Int J Cancer       Date:  2004-03-01       Impact factor: 7.396

6.  Proprotein convertase PC1/3-related peptides are potent slow tight-binding inhibitors of murine PC1/3 and Hfurin.

Authors:  A Boudreault; D Gauthier; C Lazure
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

7.  The multifunctional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing, and routing domains.

Authors:  L H Ouafik; D A Stoffers; T A Campbell; R C Johnson; B T Bloomquist; R E Mains; B A Eipper
Journal:  Mol Endocrinol       Date:  1992-10

8.  The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.

Authors:  Miroslav S Sarac; Angus Cameron; Iris Lindberg
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.609

9.  Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.

Authors:  M Mbikay; F Sirois; J Yao; N G Seidah; M Chrétien
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Lack of integrin alpha-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo.

Authors:  M Lehmann; V Rigot; N G Seidah; J Marvaldi; J C Lissitzky
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.766

View more
  6 in total

1.  Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.

Authors:  Claude Lalou; Nathalie Scamuffa; Samia Mourah; Francois Plassa; Marie-Pierre Podgorniak; Nadem Soufir; Nicolas Dumaz; Fabien Calvo; Nicole Basset-Seguin; Abdel-Majid Khatib
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

2.  Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.

Authors:  Nathalie Scamuffa; Geraldine Siegfried; Yannick Bontemps; Liming Ma; Ajoy Basak; Ghislaine Cherel; Fabien Calvo; Nabil G Seidah; Abdel-Majid Khatib
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 3.  Peptide processing and biology in human disease.

Authors:  Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

4.  Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.

Authors:  Gero L Becker; Frank Sielaff; Manuel E Than; Iris Lindberg; Sophie Routhier; Robert Day; Yinghui Lu; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

Review 5.  Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Authors:  Yannick Bontemps; Nathalie Scamuffa; Fabien Calvo; Abdel-Majid Khatib
Journal:  Med Res Rev       Date:  2007-09       Impact factor: 12.944

6.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.

Authors:  Xiaowei Sun; Rachid Essalmani; Nabil G Seidah; Annik Prat
Journal:  Mol Cancer       Date:  2009-09-08       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.